

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lumason® Infusion vs. Bolus Administrations
Details : Lumason is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 06, 2024
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : NaviFUS
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lumason is a drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Glioblastoma.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 26, 2024
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : NaviFUS
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Burl Concepts
Deal Size : Inapplicable
Deal Type : Inapplicable
Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke
Details : Lumason is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Stroke.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 28, 2017
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Burl Concepts
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase I
Sponsor : Bracco | Pediatric Orthopaedic Society of North America
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lumason is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Developmental Dysplasia of the Hip.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 11, 2017
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase I
Sponsor : Bracco | Pediatric Orthopaedic Society of North America
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lumason is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Coronary Artery Disease.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 17, 2015
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lumason is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Coronary Artery Disease.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 13, 2015
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sulfur Hexafluoride is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Rhegmatogenous Retinal Detachment, Autosomal Dominant.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 09, 2014
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Breast Lesions Characterization on Contrast Enhanced Ultrasound With Histopathological Correlation
Details : Sonovue is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Breast Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 27, 2014
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety of SonoVue on Pulmonary Hemodynamics
Details : Sonovue is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hypertension, Pulmonary.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 01, 2011
Lead Product(s) : Sulfur Hexafluoride
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
